Research Background
Project Introduction
01
Product Introduction
02
Technology Introduction
1. Independently developed CBCT - motion control system. 2. Independently developed a complete data acquisition process. 3. Multiple independently developed technologies: G-Retinex adaptive image enhancement system, N-Denoising intelligent denoising system, Auto-Dose automatic dose adjustment system, Mars artifact removal, NK-Segmentation, etc.
Project Value
Project Advantages
1. Technological Advantage: The company has mature CBCT manufacturing technology and possesses core technologies such as equipment control, data acquisition, core algorithms, and 3D reconstruction.
2. Product Advantage: Four-in-one CBCT: Ultra-large field of view full cranial imaging, wider application, and upgrading of existing domestic products. 3. Cost Advantage: The main accessories are fully replaced by domestic ones, significantly reducing costs. The product has high configuration and low price, with a 50% price reduction compared to similar domestic products. 1. The product was submitted for inspection to the Shenyang Inspection Institute in 2022. Currently, the EMC test has been completed, and the type inspection report has been obtained. It is expected to conduct clinical trials in May 2024 and obtain the CFDA certificate in 2024. 2. Currently, the team is actively developing new models of dental CBCT, industrial CT, pet CT, and orthopedic CT simultaneously.
3. Product Advantage: Four-in-one CBCT: Ultra-large field of view full cranial imaging, wider application, and upgrading of existing domestic products. 4. Cost Advantage: The main accessories are fully replaced by domestic ones, significantly reducing costs. The product has high configuration and low price, with a 50% price reduction compared to similar domestic products.1. The product was submitted for inspection to the Shenyang Inspection Institute in 2022. Currently, the EMC test has been completed, and the type inspection report has been obtained. It is expected to conduct clinical trials in May 2024 and obtain the CFDA certificate in 2024. 2. Currently, the team is actively developing new models of dental CBCT, industrial CT, pet CT, and orthopedic CT simultaneously.